ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical wins commercial pilot with US Dept of Defense
|
|
LF916227
|
52 |
20K |
9 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
52
|
20K
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
LF916227
|
111 |
35K |
4 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
111
|
35K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Pause in Trading
|
|
LF916227
|
31 |
8.3K |
7 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
31
|
8.3K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Pause in Trading
|
|
LF916227
|
31 |
8.3K |
3 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
31
|
8.3K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Pause in Trading
|
|
LF916227
|
31 |
8.3K |
3 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
31
|
8.3K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical conducts first commercial scan within VA
|
|
LF916227
|
78 |
27K |
5 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
78
|
27K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical conducts first commercial scan within VA
|
|
LF916227
|
78 |
27K |
9 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
78
|
27K
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical conducts first commercial scan within VA
|
|
LF916227
|
78 |
27K |
4 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
78
|
27K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
4 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
2.5K
|
1.1M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2023
|
|
LF916227
|
21 |
7.3K |
13 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
21
|
7.3K
|
13
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2023
|
|
LF916227
|
21 |
7.3K |
12 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
21
|
7.3K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs first US hospital SaaS contract
|
|
LF916227
|
158 |
70K |
6 |
11/04/23 |
11/04/23 |
ASX - By Stock
|
158
|
70K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs first US hospital SaaS contract
|
|
LF916227
|
158 |
70K |
3 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
158
|
70K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs first US hospital SaaS contract
|
|
LF916227
|
158 |
70K |
15 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
158
|
70K
|
15
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs first US hospital SaaS contract
|
|
LF916227
|
158 |
70K |
12 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
158
|
70K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
How low can this go, will it go under .32
|
|
LF916227
|
41 |
13K |
2 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
41
|
13K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
How low can this go, will it go under .32
|
|
LF916227
|
41 |
13K |
12 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
41
|
13K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical Reports 1H FY2023 Results
|
|
LF916227
|
5 |
3.2K |
1 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
5
|
3.2K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
0 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
2.5K
|
1.1M
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
4 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
2.5K
|
1.1M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
5 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
2.5K
|
1.1M
|
5
|
|
ASX - By Stock
|
BKW |
Re:
Next property trust valuation
|
|
LF916227
|
12 |
9.4K |
5 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
12
|
9.4K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q1 FY2023
|
|
LF916227
|
43 |
17K |
0 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
43
|
17K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q1 FY2023
|
|
LF916227
|
43 |
17K |
1 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
43
|
17K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical releases CT LVAS in Australia
|
|
LF916227
|
12 |
4.7K |
1 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
12
|
4.7K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical releases CT LVAS in Australia
|
|
LF916227
|
12 |
4.7K |
1 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
12
|
4.7K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
10 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
10
|
|
ASX - By Stock
|
BKW |
Re:
Ann: Analyst Presentation FY July 2022
|
|
LF916227
|
5 |
5.0K |
6 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
5
|
5.0K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
2 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
3 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
5 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Vanderblit 'burn pit' trial hits primary endpoint
|
|
LF916227
|
51 |
19K |
11 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
51
|
19K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Vanderblit 'burn pit' trial hits primary endpoint
|
|
LF916227
|
51 |
19K |
17 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
51
|
19K
|
17
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
7 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
2 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
2 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
0 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
0
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
LF916227
|
53 |
23K |
4 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
53
|
23K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
LF916227
|
53 |
23K |
5 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
53
|
23K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical clinical trial results presented at ATS
|
|
LF916227
|
64 |
31K |
8 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
64
|
31K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
8 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2022
|
|
LF916227
|
4 |
3.8K |
11 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
4
|
3.8K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical unveils world's first dedicated lung scanner
|
|
LF916227
|
43 |
19K |
5 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
43
|
19K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
6 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
2.5K
|
1.1M
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q2 FY2022
|
|
LF916227
|
39 |
9.0K |
10 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
39
|
9.0K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical presents at BP Healthcare Conference
|
|
LF916227
|
93 |
21K |
12 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
93
|
21K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical presents at BP Healthcare Conference
|
|
LF916227
|
93 |
21K |
6 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
93
|
21K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical presents at BP Healthcare Conference
|
|
LF916227
|
93 |
21K |
3 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
93
|
21K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
2.5K |
1.1M |
4 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Just Out.
|
|
LF916227
|
60 |
25K |
6 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
60
|
25K
|
6
|
|